Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene

Turkish Journal of Pediatrics

Volumn 45, Issue 2, 2003, Pages 99-101

  Pehlivan, Sacide ^a   Özkinay, Ferda ^b   Okutman, Özlem ^a   Çoǧulu, Özgür ^b   Özcan, Ali ^a   Çankaya, Tufan ^b   Ülgenalp, Ayfer ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Achondroplasia; DNA; Fibroblast growth factor receptor 3 gene; Restriction endonuclease analysis

Indexed keywords

ARGININE; CYSTEINE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCINE;

ACHONDROPLASIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC SIMILARITY; HETEROZYGOSITY; HUMAN; MALE; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POPULATION RESEARCH; TURKEY (REPUBLIC);

ACHONDROPLASIA; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; TURKEY;

EID: 0038262902     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gorlin RJ, Cohen MM, Levin LS. Syndromes of the Head and Neck (3rd ed) New York, Oxford University, 1990.
2. Murdoch JL, Walker BA, Hall JG, et al. Achondroplasia: a genetic and statistical survey. Ann Hum Genet 1970; 33, 227-244.
3. Gardner RJ. A new estimate of the achondroplasia mutation rate. Clin Genet 1977; 11: 31-38.
4. Stoll C, Dott B, Roth MP, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin Genet 1989; 35: 88-92.
5. Oberklaid F, Danks DM, Jensen F, eta l. Achondroplasia and hypochondroplasia: comments on frequency, mutation rate and radiological features in skull and spine. J Med Genet 1979; 16: 140-146.
6. McKusick VA. Mendelian Inheritance in Man (10th ed) New York: The John Hopkins University Press; 1992; 10-12.
7. Velinov M, Slaugenhaupt SA, Stoilov I, et al. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat Genet 1994; 6: 314-317.
8. Le Merrer M, Rousseau F, Legai-Mallet L, et al. A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nat Genet 1994; 6: 318-321.
9. Francomano CA, Ortiz de Luna RI, Hefferon TW, et al. Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. Hum Mol Genet 1994; 3: 787-792.
10. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR-3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78: 335-342.
11. Alderborn A, Anuret M, Gustavson KH, et al. Achondroplasia in Sweden caused by the G1138A mutation in FGFR-3. Acta Pediatr 1996; 85: 1506-1507.
12. Lanning RW, Brown CA. An improved methodology for the detection of the common mutation in the FGFR-3 gene responsible for achondroplasia. Hum Mut 1997; 10: 496-499.
13. Rousseau F, Bonaventure J, Legai-Mollet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371: 252-254.
14. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR-3. Am J Hum Genet 1995; 56: 368-373.
15. Miller SA, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acid Res 1988; 28: 215.
16. Ikegawa S, Fukushima Y, Isomura M, et al. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet 1995; 96: 309-311.
17. Niu DM, Hsiao KJ, Wang NH, et al. Chinese achondroplasia is also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene. Hum Genet 1996; 98: 65-67.
18. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993; 60: 1-41.
19. Meyers GA, Orlow SJ, Munro IR, et al. Fibroblast growth factor receptor-3 (FGFR3) transmembrane mutations in Crouzon syndrome with acanthosis nigricans. Nature Genet 1995; 11: 462-464.
20. Monsonego OE, Adar R, Fefermen T, et al. The transmembrane mutation, G380R in fibroblast growth factor receptor-3, uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol 2000; 20: 516-522.
21. Segev O, Chumakov I, Nevo Z, et al. Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularisation and ossification in human FGFR-3 (G380R) transgenic mice. Hum Mol Genet 2000; 9: 249-258.
22. Prinos P, Costa T, Sommer A, et al. A common FGFR3 mutation in hypochondroplasia. Hum Molec Genet 1995; 4: 2097-2101.
23. Tavormina PL, Shiang R, Thompson LM, Zhu Y-Z, Wilkin DJ, Lachman RS. Thanatophoric dysplasia (type I and II) caused by distinct mutations in fibroblast growth factor receptor. Nature Genet 1995; 9: 321-328.